Affiliations
AffiliationItem in Clipboard
Cost of services provided by the National Breast and Cervical Cancer Early Detection ProgramDonatus U Ekwueme et al. Cancer. 2014.
. 2014 Aug 15;120 Suppl 16(Suppl 16):2604-11. doi: 10.1002/cncr.28816. AffiliationItem in Clipboard
AbstractBackground: The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) is the largest cancer screening program for low-income women in the United States. This study updates previous estimates of the costs of delivering preventive cancer screening services in the NBCCEDP.
Methods: We developed a standardized web-based cost-assessment tool to collect annual activity-based cost data on screening for breast and cervical cancer in the NBCCEDP. Data were collected from 63 of the 66 programs that received funding from the Centers for Disease Control and Prevention during the 2006/2007 fiscal year. We used these data to calculate costs of delivering preventive public health services in the program.
Results: We estimated the total cost of all NBCCEDP services to be $296 (standard deviation [SD], $123) per woman served (including the estimated value of in-kind donations, which constituted approximately 15% of this total estimated cost). The estimated cost of screening and diagnostic services was $145 (SD, $38) per women served, which represented 57.7% of the total cost excluding the value of in-kind donations. Including the value of in-kind donations, the weighted mean cost of screening a woman for breast cancer was $110 with an office visit and $88 without, the weighted mean cost of a diagnostic procedure was $401, and the weighted mean cost per breast cancer detected was $35,480. For cervical cancer, the corresponding cost estimates were $61, $21, $415, and $18,995, respectively.
Conclusions: These NBCCEDP cost estimates may help policy makers in planning and implementing future costs for various potential changes to the program.
Keywords: NBCCEDP; breast cancer screening; cervical cancer screening; cost analysis; economic cost; program evaluation.
© 2014 American Cancer Society.
Conflict of interest statementCONFLICT OF INTEREST DISCLOSURES
The authors made no disclosures.
FiguresFigure 1
Summary of CAT Development and…
Figure 1
Summary of CAT Development and Activity-Based Cost Data Collection Process. *The 11 modules…
Figure 1Summary of CAT Development and Activity-Based Cost Data Collection Process. *The 11 modules in CAT are: 1) Grantee details; (2) Total funding; (3) In-kind contribution, (4) Personnel expenditure: (5) Consultant expenditure; (6) Screening expenditure; (7) Expenditure for non-screening activities performed by health departments/centers or providers; (8) Expenditures associated with contracts, materials, travel and services; (9) Administrative expenditures; (10) Resource allocation to breast versus cervical cancer screening for selected activities; and (11) Screening and diagnostic activities supported through the use of non-federal funds.
Figure 2
Estimated Distribution of Weighted Mean…
Figure 2
Estimated Distribution of Weighted Mean Costs and Percent Distribution per Woman Served, by…
Figure 2Estimated Distribution of Weighted Mean Costs and Percent Distribution per Woman Served, by Program Component. Estimates exclude the value of in-kind contributions, the numbers in parentheses are standard deviation, and the numbers in brackets are % distribution of cost per woman served by program component.
Figure 3
Average Cost per Woman Served…
Figure 3
Average Cost per Woman Served by Number of Women Served in NBCCEDP during…
Figure 3Average Cost per Woman Served by Number of Women Served in NBCCEDP during 2006/2007 Fiscal Year.
Similar articlesTrogdon JG, Ekwueme DU, Subramanian S, Miller JW, Wong FL. Trogdon JG, et al. Cancer Causes Control. 2019 Aug;30(8):813-818. doi: 10.1007/s10552-019-01190-2. Epub 2019 Jun 11. Cancer Causes Control. 2019. PMID: 31187351 Free PMC article.
Ekwueme DU, Gardner JG, Subramanian S, Tangka FK, Bapat B, Richardson LC. Ekwueme DU, et al. Cancer. 2008 Feb 1;112(3):626-35. doi: 10.1002/cncr.23207. Cancer. 2008. PMID: 18157831
Lawson HW, Henson R, Bobo JK, Kaeser MK. Lawson HW, et al. MMWR Recomm Rep. 2000 Mar 31;49(RR-2):37-55. MMWR Recomm Rep. 2000. PMID: 15580731
Khan K, Curtis CR, Ekwueme DU, Stokley S, Walker C, Roland K, Benard V, Saraiya M. Khan K, et al. Cancer. 2008 Nov 15;113(10 Suppl):3004-12. doi: 10.1002/cncr.23765. Cancer. 2008. PMID: 18980296 Review.
Phillips V, Franco Montoya D, Adams EK. Phillips V, et al. Cancers (Basel). 2024 Mar 13;16(6):1134. doi: 10.3390/cancers16061134. Cancers (Basel). 2024. PMID: 38539469 Free PMC article. Review.
Chesson HW, Meites E, Ekwueme DU, Saraiya M, Markowitz LE. Chesson HW, et al. Hum Vaccin Immunother. 2019;15(7-8):1942-1948. doi: 10.1080/21645515.2019.1603562. Epub 2019 May 20. Hum Vaccin Immunother. 2019. PMID: 31107640 Free PMC article. Review.
Ryerson AB, Miller J, Eheman CR. Ryerson AB, et al. Cancer Causes Control. 2015 May;26(5):733-40. doi: 10.1007/s10552-015-0544-1. Epub 2015 Mar 10. Cancer Causes Control. 2015. PMID: 25754109 Free PMC article.
Trogdon JG, Ekwueme DU, Subramanian S, Miller JW, Wong FL. Trogdon JG, et al. Cancer Causes Control. 2019 Aug;30(8):813-818. doi: 10.1007/s10552-019-01190-2. Epub 2019 Jun 11. Cancer Causes Control. 2019. PMID: 31187351 Free PMC article.
Subramanian S, Ekwueme DU, Miller JW, Khushalani JS, Trogdon JG, Wong FL. Subramanian S, et al. Cancer Causes Control. 2019 Aug;30(8):827-834. doi: 10.1007/s10552-019-01174-2. Epub 2019 May 20. Cancer Causes Control. 2019. PMID: 31111278 Free PMC article.
Musa J. Musa J. Afr J Reprod Health. 2017 Dec;21(4):17-23. doi: 10.29063/ajrh2017/v21i4.2. Afr J Reprod Health. 2017. PMID: 29624947 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3